Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Immunotherapies for neurodegenerative diseases: current status and potential of plant-made biopharmaceuticals.
Higher minor hemoglobin A2 levels in multiple sclerosis patients correlate with lesser disease severity.
Pathogenic inflammation in the CNS of mice carrying human PLP1 mutations.
Babesia parasitemia rebound after red blood cell exchange.
A consensus initiative for the assessment of patients newly diagnosed with multiple sclerosis in Spain: the eXamina Project.
Ultrastructural, ssrDNA sequencing of Myxobolus prochilodus and Myxobolus porofilus and details of the interaction with the host Prochilodus lineatus.
Prolonged-release fampridine treatment improved subject-reported impact of multiple sclerosis: Item-level analysis of the MSIS-29.
Mesenchymal Stromal/Stem Cells Do Not Ameliorate Experimental Autoimmune Encephalomyelitis and Are Not Detectable in the Central Nervous System of Transplanted Mice.
The history of myelin.
Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions.
Common genetic variants in the plasminogen activation pathway are not associated with multiple sclerosis.
GSK3β Promotes the Differentiation of Oligodendrocyte Precursor Cells via β-Catenin-Mediated Transcriptional Regulation.
Antioxidant Protection of NADPH-Depleted Oligodendrocyte Precursor Cells Is Dependent on Supply of Reduced Glutathione.
Author Response.
Default mode network changes in multiple sclerosis: a link between depression and cognitive impairment?
Comprehension of confidence intervals - development and piloting of patient information materials for people with multiple sclerosis: qualitative study and pilot randomised controlled trial.
g-Ratio weighted imaging of the human spinal cord in vivo.
Interferon-β therapy specifically reduces pathogenic memory B cells in Multiple Sclerosis patients by inducing a FAS-mediated apoptosis.
Subgroup and sensitivity analyses of annualized relapse rate over 2 years in the ADVANCE trial of peginterferon beta-1a in patients with relapsing-remitting multiple sclerosis.
Haematopoietic stem cell transplantation in autoimmune diseases: From basic science to clinical practice.
Orderly Steps in Progression of JC Virus to Virulence in the Brain.
Longitudinal time-domain optic coherence study of retinal nerve fiber layer in IFNβ-treated and untreated multiple sclerosis patients.
FDA Drug Safety Communication: FDA warns about cases of rare brain infection with MS drug Gilenya (fingolimod) in two patients with no prior exposure to immunosuppressant drugs
Effect of thyreotrope-releasing hormone (TRH) on prolactin turnover in culture.
The Impact of the Nurses' Health Study on Population Health: Prevention, Translation, and Control.

Pages